Showing 228,681 - 228,700 results of 230,332 for search '(( 5 ((fold decrease) OR (point decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 2.58s Refine Results
  1. 228681

    Image_3_OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-R... by Wei Peng (432211)

    Published 2022
    “…Besides, PD-1 inhibitor (nivolumab) improved the cytotoxic activity of OCT4&SOX2 CTLs against MCF7-BCSCs in a dose-dependent manner. In vivo, OCT4&SOX2 CTLs plus PD-1 inhibitor (nivolumab) decreased tumor volume and tumor weight while increased tumor apoptosis rate compared to OCT4&SOX2 CTLs alone, PD-1 inhibitor (nivolumab) alone, and control.…”
  2. 228682

    Telomere length regulates Fst/BMP/pSmad signaling. by Na Liu (102929)

    Published 2019
    “…<p>(A) Scatter plots showing global differential gene expression profile of WT and G4 <i>Terc</i><sup>–/–</sup>ES cells. …”
  3. 228683

    Image_1_OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-R... by Wei Peng (432211)

    Published 2022
    “…Besides, PD-1 inhibitor (nivolumab) improved the cytotoxic activity of OCT4&SOX2 CTLs against MCF7-BCSCs in a dose-dependent manner. In vivo, OCT4&SOX2 CTLs plus PD-1 inhibitor (nivolumab) decreased tumor volume and tumor weight while increased tumor apoptosis rate compared to OCT4&SOX2 CTLs alone, PD-1 inhibitor (nivolumab) alone, and control.…”
  4. 228684

    Data_Sheet_1_Nano- and Macroscale Study of the Lubrication of Titania Using Pure and Diluted Ionic Liquids.pdf by Peter K. Cooper (1345383)

    Published 2019
    “…The macrotribology measurements demonstrated that friction decreased in P<sub>6,6,6,14</sub> TFSI by four times (μ = 0.13) compared to in hexadecane, even at 60°C and loads up to 10 N. …”
  5. 228685

    Image_2_OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-R... by Wei Peng (432211)

    Published 2022
    “…Besides, PD-1 inhibitor (nivolumab) improved the cytotoxic activity of OCT4&SOX2 CTLs against MCF7-BCSCs in a dose-dependent manner. In vivo, OCT4&SOX2 CTLs plus PD-1 inhibitor (nivolumab) decreased tumor volume and tumor weight while increased tumor apoptosis rate compared to OCT4&SOX2 CTLs alone, PD-1 inhibitor (nivolumab) alone, and control.…”
  6. 228686
  7. 228687
  8. 228688
  9. 228689
  10. 228690

    Table 1_Uniaxial tensile material properties of adult Chinese dura mater: investigating the influence of age, sex, and anatomical site.docx by Jinming Wang (191356)

    Published 2025
    “…</p>Results<p>indicated significant age-related degradation: E<sub>C</sub>, σ<sub>Tf</sub>, ε<sub>Tf</sub>; and MaxForce significantly decreased with age (median E<sub>C</sub> declined from 28.0 MPa in young adults to 15.3 MPa in the elderly, P < 0.05; median ε<sub>Tf</sub> from 0.215 to 0.156, P < 0.05), while E<sub>E</sub> showed no significant age correlation (P = 0.10). …”
  11. 228691

    γδ T cells have similar TCR threshold but enhanced ERK1/2 phosphorylation comparing to αβ T cells. by Hsin-Yuan Cheng (414160)

    Published 2013
    “…<p>(A) Percentages of BrdU<sup>+</sup> proliferative cells are higher in the γδ T cell subset <i>in vivo</i>. …”
  12. 228692

    Phenotypic characterisation of CD4CD25T cells from immunised IFN-γR KO and wild-type DBA/1 mice by Hilde Kelchtermans (12561)

    Published 2011
    “…</p> CD4CD25T cells isolated from IFN-γR KO and wild-type mice show a similar expression pattern of activation markers, in naive and immunised conditions. …”
  13. 228693

    Aryl-Fluoride Reductive Elimination from Pd(II):  Feasibility Assessment from Theory and Experiment by Dmitry V. Yandulov (2507068)

    Published 2007
    “…Three-coordinate T-shaped geometry of Pd<sup>II</sup>Ar(F)L (L = NHC, PR<sub>3</sub>) was shown to offer kinetics and thermodynamics of Ar−F elimination largely compatible with synthetic applications, whereas coordination of strong fourth ligands to Pd or association of hydrogen bond donors with F each caused pronounced stabilization of Pd(II) reactant and increased activation barrier beyond the practical range. Decreasing donor ability of L promotes elimination kinetics via increasing driving force and <i>para</i>-substituents on Ar exert a sizable S<sub>N</sub>Ar-type TS effect. …”
  14. 228694

    IKKε interacts with PML and disrupts the PML nuclear bodies. by Xiaoqian Wang (460263)

    Published 2025
    “…<p>(<i>A</i>) IKKε interacts with PML. HEK293T cells were co-transfected with indicated plasmids and cell lysates were subjected to IP and IB with indicated antibodies. …”
  15. 228695
  16. 228696

    Inhibition of tumorgeneic activity in Oct-4 siRNA-treated LC-CD133<sup>+</sup> with chemoradiotherapy. by Yu-Chih Chen (151468)

    Published 2008
    “…(A) The tumor volume and (B) The number of pulmonary tumor nodules were significantly decreased in Oct-4 siRNA-treated LC-CD133<sup>+</sup> when exposed to IR alone, cisplatin alone, or IR combined with cisplatin. …”
  17. 228697

    DataSheet_1_Etiologic characteristics revealed by mNGS-mediated ultra-early and early microbiological identification in airway secretions from lung transplant recipients.xlsx by Xiaoqin Zhang (517854)

    Published 2023
    “…Within one month, 26 (68.42%) recipients got infected (with a median time of 9 days), among which 10 (38.46%) cases were infected within one week. …”
  18. 228698

    Table 1_Global, regional, and national trends in DALYs for blindness and vision loss in teenagers and young adults, 1990–2019: an age-period-cohort analysis based on the Global Bur... by Juan Lu (275293)

    Published 2025
    “…As reflected by local drift, the DALYs had decreasing trends across all age groups, except in high SDI countries. …”
  19. 228699
  20. 228700